Does preoperative MRI accurately stratify early-stage HER2 + breast cancer patients to upfront surgery vs neoadjuvant chemotherapy? Astrid Botty van den BrueleEmanuela FerraroVirgilio Sacchini Review 14 July 2021 Pages: 307 - 315
SLC1A5 co-expression with TALDO1 associates with endocrine therapy failure in estrogen receptor-positive breast cancer Lutfi H. AlfarsiRokaya El AnsariAndrew R. Green Preclinical study Open access 19 July 2021 Pages: 317 - 331
Nonphosphorylatable PEA15 mutant inhibits epithelial-mesenchymal transition in triple-negative breast cancer partly through the regulation of IL-8 expression Jihyun ParkMoises J. TacamChandra Bartholomeusz Preclinical study Open access 09 July 2021 Pages: 333 - 345
KMT2C is a potential biomarker of prognosis and chemotherapy sensitivity in breast cancer Xinhua LiuRongfang QiuYang Yang Preclinical study 08 July 2021 Pages: 347 - 361
Increased gene expression variability in BRCA1-associated and basal-like breast tumours George A. R. WigginsMichael A. BlackLogan C. Walker Preclinical study Open access 21 July 2021 Pages: 363 - 375
Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer Rebecca DentMafalda Oliveiraon behalf of the LOTUS investigators Clinical trial 15 July 2021 Pages: 377 - 386
Health-related quality of life of early-stage breast cancer patients after different radiotherapy regimens Daphne H. M. JacobsRamona K. CharaghvandiHelena M. Verkooijen Clinical trial Open access 03 July 2021 Pages: 387 - 398
Combining method of detection and 70-gene signature for enhanced prognostication of breast cancer J. M. N. Lopes CardozoM. K. SchmidtC. A. Drukker Clinical trial 30 June 2021 Pages: 399 - 410
A phase II study of efficacy, toxicity, and the potential impact of genomic alterations on response to eribulin mesylate in combination with trastuzumab and pertuzumab in women with human epidermal growth factor receptor 2 (HER2)+ metastatic breast cancer Sara M. BalchInes Vaz-LuisRachel A. Freedman Clinical trial 24 July 2021 Pages: 411 - 423
The impact of hyperbaric oxygen therapy on late radiation toxicity and quality of life in breast cancer patients Marilot C. T. BatenburgWies MaarseHelena M. Verkooijen Clinical trial Open access 19 July 2021 Pages: 425 - 433
Pre-diagnostic DNA methylation patterns differ according to mammographic breast density amongst women who subsequently develop breast cancer: a case-only study in the EPIC-Florence cohort Saverio CainiGiovanni FioritoGiovanna Masala Epidemiology 08 June 2021 Pages: 435 - 444
New and persistent controlled substance use among patients undergoing mastectomy and reconstructive surgery Jacob C. CoganRohit R. RaghunathanDawn L. Hershman Epidemiology 04 June 2021 Pages: 445 - 454
A 95-gene signature stratifies recurrence risk of invasive disease in ER-positive, HER2-negative, node-negative breast cancer with intermediate 21-gene signature recurrence scores Takeo FujiiHiroko MasudaNaoto T. Ueno Epidemiology 15 June 2021 Pages: 455 - 461
Does margin width impact breast cancer recurrence rates in women with breast conserving surgery for ductal carcinoma in situ? Devon Livingston-RosanoffAmy Trentham-DietzLee G. Wilke Epidemiology 15 June 2021 Pages: 463 - 470
Prognostic factors for residual occult disease in shave margins during partial mastectomy Julie B. SiegelRupak MukherjeeAndrea M. Abbott Epidemiology 16 June 2021 Pages: 471 - 481
Impact of breast cancer risk factors on clinically relevant prognostic biomarkers for primary breast cancer Mustapha AbubakarChangyuan GuoXiaohong R. Yang Epidemiology Open access 29 June 2021 Pages: 483 - 495
Psychological consequences of MRI-based screening among women with strong family histories of breast cancer Matthew CasteloZachary BrownAdena S. Scheer Epidemiology 02 July 2021 Pages: 497 - 508
Suboptimal therapy following breast conserving surgery in triple-negative and HER2-positive breast cancer patients Jeffrey E. JohnsonPaula D. StrassleStephanie Downs-Canner Epidemiology 26 June 2021 Pages: 509 - 520
Longitudinal study of inflammatory, behavioral, clinical, and psychosocial risk factors for chemotherapy-induced peripheral neuropathy Ian R. KlecknerTodd A. JuskoKaren M. Mustian Epidemiology 30 June 2021 Pages: 521 - 532
Germline variants in hereditary breast cancer genes are associated with early age at diagnosis and family history in Guatemalan breast cancer Megan RenAnali OrozcoMichael Dean Epidemiology Open access 01 July 2021 Pages: 533 - 539
The association of socioeconomic status on treatment strategy in patients with stage I and II breast cancer in the Netherlands M. D. FilipeS. SieslingA. J. Witkamp Epidemiology Open access 26 June 2021 Pages: 541 - 550
Variations in pathways and resource use in follow-up after abnormal mammography screening: a nationwide register-based study Susanne Fogh JørgensenBerit AndersenSisse Helle Njor Epidemiology 01 July 2021 Pages: 551 - 560
Screen-detected breast cancer is associated with better prognosis and survival compared to self-detected/symptomatic cases in a Chilean cohort of female patients Benjamin WalbaumKlaus PuschelCésar Sánchez Epidemiology 10 July 2021 Pages: 561 - 569
Serum zinc and dietary intake of zinc in relation to risk of different breast cancer subgroups and serum levels as a marker of intake: a prospective nested case-control study Ylva BengtssonMalte SandsvedenJonas Manjer Epidemiology Open access 05 July 2021 Pages: 571 - 583
Medication use and mammographic breast density Yunan HanChee Teik LeeAdetunji T. Toriola Epidemiology 01 July 2021 Pages: 585 - 592
